CeriBell (NASDAQ:CBLL) CFO Scott Blumberg Sells 652 Shares of Stock

CeriBell, Inc. (NASDAQ:CBLL) CFO Scott Blumberg sold 652 shares of the business’s stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $25.00, for a total value of $16,300.00. Following the completion of the transaction, the chief financial officer directly owned 146,600 shares of the company’s stock, valued at approximately $3,665,000. The trade was a 0.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Scott Blumberg also recently made the following trade(s):

• On Friday, August 21st, Scott Blumberg sold 1,521 shares of CeriBell stock. The shares were sold at an average price of $24.02, for a total value of $36,534.42.
• On Wednesday, August 19th, Scott Blumberg sold 33,512 shares of CeriBell stock. The shares were sold at an average price of $25.03, for a total value of $838,805.36.
• On Tuesday, August 18th, Scott Blumberg sold 990 shares of CeriBell stock. The stock was sold at an average price of $25.00, for a total transaction of $24,750.00.

CeriBell Price Performance

Shares of NASDAQ CBLL opened at $24.72 on Friday. The company has a debt-to-equity ratio of 0.16, a current ratio of 9.18 and a quick ratio of 8.79. The business has a 50-day moving average of $20.67 and a 200-day moving average of $19.49. The stock has a market capitalization of $948.75 million, a price-to-earnings ratio of -14.05 and a beta of 0.95. CeriBell, Inc. has a fifty-two week low of $10.85 and a fifty-two week high of $25.33.

CeriBell (NASDAQ:CBLL) last announced its quarterly earnings data on Monday, August 10th. The company reported ($0.51) EPS for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.04). The firm had revenue of $28.10 million during the quarter, compared to the consensus estimate of $27.28 million. CeriBell had a negative net margin of 64.73% and a negative return on equity of 44.85%. As a group, sell-side analysts predict that CeriBell, Inc. will post -1.96 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently commented on CBLL shares. Raymond James Financial reiterated a “strong-buy” rating and issued a $29.00 price target on shares of CeriBell in a research note on Thursday. BTIG Research lifted their price target on CeriBell from $28.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, August 18th. Barclays raised CeriBell to a “neutral” rating in a report on Tuesday, August 18th. Weiss Ratings lowered shares of CeriBell from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, August 28th. Finally, Canaccord Genuity Group increased their target price on shares of CeriBell from $25.00 to $26.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, CeriBell currently has an average rating of “Moderate Buy” and a consensus price target of $24.40.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of CBLL. Russell Investments Group Ltd. increased its holdings in CeriBell by 41.4% in the 4th quarter. Russell Investments Group Ltd. now owns 2,918 shares of the company’s stock valued at $64,000 after buying an additional 854 shares during the period. Sei Investments Co. boosted its position in shares of CeriBell by 2.3% during the 1st quarter. Sei Investments Co. now owns 50,360 shares of the company’s stock worth $923,000 after acquiring an additional 1,125 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its stake in CeriBell by 3,971.0% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company’s stock valued at $28,000 after acquiring an additional 1,231 shares during the last quarter. Deutsche Bank AG increased its stake in CeriBell by 1.7% in the fourth quarter. Deutsche Bank AG now owns 85,182 shares of the company’s stock valued at $1,868,000 after acquiring an additional 1,393 shares during the last quarter. Finally, Strs Ohio bought a new stake in CeriBell during the first quarter worth $27,000.

About CeriBell

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.